We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

U.S. Appeals Court Upholds Generic Zocor's Exclusivity

Law360 (November 14, 2006, 12:00 AM EST) -- A U.S. appeals court Tuesday upheld a district court ruling giving pharmaceutical companies Teva and Ranbaxy the exclusive rights to sell a generic version of Merck & Co. Inc.’s popular cholesterol drug Zocor.

The U.S. Court of Appeals for District of Columbia Circuit affirmed the lower court’s decision that the Food and Drug Administration erred when it denied Israel-based Teva Pharmaceutical Industries Ltd. and India-based Ranbaxy Laboratories Ltd. an exclusive marketing period for their generic drug.

Teva and Ranbaxy will continue to sell their drug without...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.